Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
BACKGROUND: The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-associated tuberculous meningitis is unknown. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of immediate versus deferred ART in patients with HIV-associated tuberc...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| Online-Zugang: | https://demo7.dspace.org/handle/123456789/147 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
Ähnliche Einträge: Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
- The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis
- Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis
- The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
- Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study
- Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study
- Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: Diagnostic value and relationship to disease severity and outcome